IDH2 and astrocytoma (excluding glioblastoma): A subgroup like astrocytoma shared less difference of OS among patients when TMZ was used with IDH1 mutant (log rank = 0.9) while the same histology patients had relatively better OS for IDH wild-type phenotypes (log-rank p = 0.09).